LakeShore Biopharma Co (LakeShore Biopharma Co) Price-to-Tangible-Book : 1.18 (As of Jun. 02, 2024)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Price-to-Tangible-Book?

As of today (2024-06-02), LakeShore Biopharma Co's share price is $0.835. LakeShore Biopharma Co's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was $0.71. Hence, LakeShore Biopharma Co's Price to Tangible Book Ratio of today is 1.18.

The historical rank and industry rank for LakeShore Biopharma Co's Price-to-Tangible-Book or its related term are showing as below:

LSB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.13 Med: 1.36 Max: 1.58
Current: 1.18

During the past 3 years, LakeShore Biopharma Co's highest Price to Tangible Book Ratio was 1.58. The lowest was 1.13. And the median was 1.36.

LSB's Price-to-Tangible-Book is ranked better than
80.43% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs LSB: 1.18

A closely related ratio is called PB Ratio. As of today, LakeShore Biopharma Co's share price is $0.835. LakeShore Biopharma Co's Book Value per Sharefor the quarter that ended in Sep. 2023 was $0.82. Hence, LakeShore Biopharma Co's P/B Ratio of today is 1.02.

LakeShore Biopharma Co Price-to-Tangible-Book Historical Data

The historical data trend for LakeShore Biopharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Price-to-Tangible-Book Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Price-to-Tangible-Book

1.58

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial			-	-	-	1.58	1.13

Competitive Comparison of LakeShore Biopharma Co's Price-to-Tangible-Book

For the Biotechnology subindustry, LakeShore Biopharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Price-to-Tangible-Book falls into.

LakeShore Biopharma Co Price-to-Tangible-Book Calculation

LakeShore Biopharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	0.835	/	0.71
	=	1.18

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

LakeShore Biopharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.